Join the discussion — anonymously
Sign in to comment, reply, and vote. Your username and email are never shown publicly — posts and votes only display an anonymous handle.
Comments (2)
It's definitely unsettling to see these kinds of announcements, especially when they hit close to home. I haven't heard anything concrete about the long-term strategy beyond the usual 'streamlining,' but the frequency of these cuts is concerning. It makes you wonder if certain therapeutic areas are being de-prioritized, or if it's a larger restructuring. Hopefully, there's a clear plan for the remaining staff and a path forward that ensures stability.
I can understand the anxiety. These 'efficiency drives' can feel like a constant undercurrent of uncertainty. From what I've gathered from internal communications, the focus seems to be on aligning resources with key growth areas, but the impact on existing teams is undeniable. It's a tough environment when job security feels precarious, and I hope leadership provides more transparency soon about where the company is headed.